Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Business, Policy & Funding » Business News » Cynvenio, St. Luke's Partner on Breast Cancer Study

Cynvenio, St. Luke's Partner on Breast Cancer Study

Aug 17, 2017
|
staff reporter

NEW YORK (GenomeWeb) – Cynvenio Biosystems today announced the launch of a breast cancer monitoring study in partnership with Saint Luke's Cancer Institute.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Severity Predictor

23andMe has launched a new tool that estimates someone's risk of developing severe COVID-19 if infected, Bloomberg reports.

Pasteur Ends Vaccine Push

The Guardian reports that Pasteur Institute researchers are halting their development of a SARS-CoV-2 vaccine following disappointing initial results.

Shift Younger

The Wall Street Journal reports that an increased number of younger patients have been hospitalized as the new SARS-CoV-2 strain spread across the UK.

Cell Studies on COVID-19 Autopsy Proteomics, Human Intestinal Development, Macaque Brain Map

In Cell this week: proteomic patterns among COVID-19 affected tissue samples, transcriptome atlas of developing intestines, and more.

What's Popular?

In Business News

  1. Encodia Closes $75M Series C Round

  2. Tempus, Bristol Myers Squibb Expand Cancer Biomarker Alliance

  3. Personalis Prices $150M Public Stock Offering

  4. Abbott Q4 Diagnostics Revenues Up 111 Percent, FY20 Revenues Up 9 Percent

  5. T2 Biosystems Preliminary Q4 Revenues Grow 155 Percent, Miss Estimates

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.